Yuki Kageyama to Cell Line, Tumor
This is a "connection" page, showing publications Yuki Kageyama has written about Cell Line, Tumor.
Connection Strength
0.270
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
Score: 0.139
-
Suppression of mutant androgen receptors by flutamide. Int J Urol. 2009 May; 16(5):516-21.
Score: 0.049
-
Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation. FASEB J. 2004 Jun; 18(9):1028-30.
Score: 0.035
-
Development of a novel interferon-a2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2014; 19(3):497-504.
Score: 0.016
-
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate. 2008 Oct 01; 68(14):1570-81.
Score: 0.012
-
Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6012-7.
Score: 0.010
-
Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. Am J Physiol Endocrinol Metab. 2004 Jun; 286(6):E927-31.
Score: 0.009